AGL Resources acquires Nicor for $2.5 billion as the consolidation trend continues in the natural gas industry
Gilead charms Pharmasset for potential Hep C blockbuster
by ,
November 21, 2011, 2:22 PM
0November 21, 2011, 2:22 PM
Pharmasset’s pumpkin carriage arrived this morning in the form of an $11 billion acquisition agreement from Gilead Sciences. The firm’s Cinderella story is a shining example of how sharply a [...]
Teva maintains strong pharma footing with Cephalon buy
by ,
October 11, 2011, 3:06 PM
0October 11, 2011, 3:06 PM
Teva Pharmaceutical Industries is a generics powerhouse that just won’t quit. And the $6.8 billion acquisition of Cephalon, expected to close later this week, gives Teva additional strength in pain [...]
Medco/Express Scripts merger sparks anti-competition debate
by ,
July 22, 2011, 11:41 AM
0July 22, 2011, 11:41 AM
Yesterday’s announcement of Express Script’s proposed $29 billion acquisition of another top PBM (pharmacy benefits management) firm, Medco Health Solutions, came with a full gamut of promises on how the combination [...]
Bizarre Pittsburgh proposal: will Highmark – West Penn merger work?
by ,
June 29, 2011, 11:49 AM
8June 29, 2011, 11:49 AM
An interesting tidbit in the news yesterday had the Hoover’s health care industry team buzzing: a major regional health insurance provider, Highmark, wants to acquire a major regional hospital operator, West [...]
INC Research strikes a match with Kendle International, fans CRO consolidation flame
by ,
May 5, 2011, 1:21 PM
0May 5, 2011, 1:21 PM
INC Research’s agreement to purchase Kendle International marks a consolidation trend in the CRO market. The merger will allow the companies to compete against top players for large pharmaceutical development contracts.
Will a Synthes implant improve J&J’s standing?
by ,
April 28, 2011, 3:47 PM
0April 28, 2011, 3:47 PM
In a highly anticipated announcement, Johnson & Johnson cut a deal this week to acquire orthopedic device maker Synthes. The $21 billion purchase had been the topic of rumors since mid-April, [...]
Valeant boldly bids for Cephalon, making $5.7 billion hostile offer to entice shareholders
by ,
March 30, 2011, 1:09 PM
0March 30, 2011, 1:09 PM
Valeant Pharmaceuticals has revealed its desire to move into the fast lane of an already racing pharma M&A market with the announcement of a $5.7 billion offerto acquire fellow drugmaker [...]
Sanofi and Genzyme ready to post marriage banns?
by ,
January 31, 2011, 5:10 PM
1January 31, 2011, 5:10 PM
After months of well publicized pre-marital squabbles, Sanofi-Aventis and Genzyme appear to be coming to terms with their differences and may even be ready to announce their impending nuptials. Like [...]
Recent Comments